Therapeutic antibodies have revolutionized the field of targeted therapy by specifically recognizing and binding to tumor biomarkers, thereby enabling precise treatment strateiges. Therapeutic antibody development involves target identification, antibody generation, screening & selection, preclinical studies, clinical trials, regulatory approval, and finally, commercial production. The innovation and significant of therapeutic antibody development lie in the precise targeting, improved efficacy, and expanded therapeutic options for patients. To support the entire journey of therapeutic antibody development, from discovery to market, we provide solutions throughout the entire development workflow. Spanning from discovery and development to clinical applications, we are dedicated to delivering solutions designed to help you drive innovation and push the boundaries of what therapeutic antibodies can be.